|1.||Coronary Disease (Coronary Heart Disease)
06/01/1984 - "It is concluded from these results that the clinical improvement of the patients with coronary heart disease treated by KC 046 is caused by a significant shift of blood volume from the thoracic region into the abdomen and the legs, thus decreasing the preload of the left ventricle."
06/01/1984 - "To evaluate the effects of the new compound teopranitol (KC 046) on blood volume distribution scintigraphic measurements were performed in 10 patients with coronary heart disease. "
|2.||Body Weight (Weight, Body)
06/01/1984 - "The differences in blood volume distribution were calculated by the ratio of the impulse rates thorax/abdomen, thorax/thigh, thorax/shank and heart/total impulse rates assessed by scintigraphy, following in vivo labeling of red blood cells with 99m-Tc, before and after i.v. injection of 0.04 mg KC 046/kg body weight. "